NCT00914277View on ClinicalTrials.gov

SAR407899 Single-dose in Treatment of Mild to Moderate Erectile Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

October 31, 2009

Conditions
Erectile Dysfunction
Interventions
DRUG

SAR407899

Oral administration

DRUG

Placebo

Oral administration

DRUG

Sildenafil

Oral administration

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Paris

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY